Pluri Inc. — Director's Dealing 2021

Jul 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2021-07-15

Reporting Person: Shalev Varda (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-15	Restricted Stock Units	A	20000	—	Acquired	20000	Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal instalments every 3 months thereafter.